CSWYF (China Shineway Pharmaceutical Group) Days Payable: 158.08 (As of Dec. 2025) — 33% Above Median


CSWYF China Shineway Pharmaceutical Group Ltd CSWYF
92 GF Score
Price $1.00
GF Value $0.88
! 2 Warning Signs
View Full Analysis

What is China Shineway Pharmaceutical Group Days Payable?

China Shineway Pharmaceutical Group CSWYF 92 Days Payable is 158.08 as of Dec. 2025, which is 33% above its 10-year median of 118.96. GuruFocus rates CSWYF with a GF Score™ of 92/100 and a GF Value™ of $0.88. The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, China Shineway Pharmaceutical Group ranks better than 75.95% on this metric.

China Shineway Pharmaceutical Group's average Accounts Payable for the six months ended in Dec. 2025 was $50.4 Mil. China Shineway Pharmaceutical Group's Cost of Goods Sold for the six months ended in Dec. 2025 was $58.2 Mil. Hence, China Shineway Pharmaceutical Group's Days Payable for the six months ended in Dec. 2025 was 158.08.

The historical rank and industry rank for China Shineway Pharmaceutical Group's Days Payable or its related term are showing as below:

CSWYF' s Days Payable Range Over the Past 10 Years
Min: 87.02   Med: 118.96   Max: 173.5
Current: 155.28

During the past 13 years, China Shineway Pharmaceutical Group's highest Days Payable was 173.50. The lowest was 87.02. And the median was 118.96.

CSWYF's Days Payable is ranked better than
75.95% of 923 companies
in the Drug Manufacturers industry
Industry Median: 90.98 vs CSWYF: 155.28

China Shineway Pharmaceutical Group's Days Payable declined from Dec. 2024 (182.87) to Dec. 2025 (158.08). It may suggest that China Shineway Pharmaceutical Group accelerated paying its suppliers.


China Shineway Pharmaceutical Group Days Payable Related Terms


China Shineway Pharmaceutical Group Days Payable Historical Data

* Premium members only.

The historical data trend for China Shineway Pharmaceutical Group's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Shineway Pharmaceutical Group Days Payable Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.24 100.77 130.24 173.05 153.24

China Shineway Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.56 169.06 182.87 154.06 158.08

CSWYF vs ZTS: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Shineway Pharmaceutical Group Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Days Payable distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's Days Payable falls into.


CSWYF
92GF Score
China Shineway Pharmaceutical Group Ltd CSWYF
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Shineway Pharmaceutical Group Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

China Shineway Pharmaceutical Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (55.347 + 48.277) / 2 ) / 123.412*365
=51.812 / 123.412*365
=153.24

China Shineway Pharmaceutical Group's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (52.598 + 48.277) / 2 ) / 58.229*365 / 2
=50.4375 / 58.229*365 / 2
=158.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 158.08 mean?
China Shineway Pharmaceutical Group (CSWYF) has a Days Payable of 158.08 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 33% above median its historical median of 118.96. Over the past decade, China Shineway Pharmaceutical Group's Days Payable has ranged from 87.02 to 173.50. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #222 out of 923 companies in the Drug Manufacturers industry, placing it in the top 24.1%.
Is China Shineway Pharmaceutical Group's Days Payable too high?
China Shineway Pharmaceutical Group's current Days Payable of 158.08 is 33% above median its 10-year median of 118.96. Over the past 10 years, this metric has ranged from a low of 87.02 to a high of 173.50. The Drug Manufacturers industry median Days Payable is 90.98. China Shineway Pharmaceutical Group's value of 158.08 is 73.8% above this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #222 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #222 out of 923 companies for Days Payable. This places China Shineway Pharmaceutical Group in the top 24% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.98. China Shineway Pharmaceutical Group's value of 158.08 is 73.8% above this benchmark. Historically, China Shineway Pharmaceutical Group's own Days Payable has ranged from 87.02 to 173.50 over the past decade. While the company's 10-year median is 118.96 vs. the industry median of 90.98, China Shineway Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current Days Payable of 158.08 is 73.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current Days Payable is 158.08, which is 33% above median its own 10-year median of 118.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYF) has a current Days Payable of 158.08. The stock's GF Value™ is $0.88, compared to a current price of $1.00 — trading 14.1% above its estimated fair value. The current Days Payable is 158.08, which is 33% above median its 10-year median of 118.96 and 73.8% above the Drug Manufacturers industry median of 90.98. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYF), the current Days Payable is 158.08 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Shineway Pharmaceutical Group (CSWYF) Overvalued in 2026?

Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued. The current stock price of $1.00 is trading 14.1% above its estimated GF Value™ of $0.88.

Key valuation signals for CSWYF:

  • Days Payable: 158.08 (33% above median its 10-year median of 118.96)
  • GF Value™: $0.88 vs. price of $1.00 (14.1% above fair value)
  • GF Score™: 92/100 with 2 warning signs
  • Industry Position: 73.8% above the Drug Manufacturers median (#222 of 923)

No single metric tells the full story. See the CSWYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Shineway Pharmaceutical Group Business Description

Other Exchanges 02877:Hong KongC1S:Germany
Address Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score

Get the complete analysis for CSWYF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.00
Price
$0.88
GF Value